Intellectual Property India Publishes Patent Application for Pharmaceutically Acceptable Salts Of Cysteamine-Pantetheine Disulfide And Uses Thereof

MUMBAI, India, Oct. 19 -- Intellectual Property India has published a patent application (202647121972 A) filed by Thiogenesis Therapeutics, Inc. on October 12, 2026, for Pharmaceutically Acceptable Salts Of Cysteamine-Pantetheine Disulfide And Uses Thereof.

Inventors include Powell, Kathlene; Rioux, Patrice P.; Wang, Xiaoyang; Li, Meiqi; and Ma, Xiaoyu.

The application for the patent was published on October 16, 2026, under issue no. 42/2026.

Abstract: The present invention composition features pharmaceutically acceptable salts of cysteamine-pantetheine disulfide and compositions thereof. The pharmaceutically acceptable salts of cysteamine-pantetheine disulfide may be used to treat a disease or condition, such as a neurological injury, ...